SLAS 2017
Washington, DC
February 4-8, 2017
Philip Gribbon represented EU-OPENSCREEN here.
Newsroom
The SLAS 2024 Sample Management Symposium brings together sample managers and technology providers to discuss best practices, digital innovation, current trends and topics related to the expansion and demands of research facilities including biospecimens, data analysis and more. This year’s symposium addresses current topics and challenges in five sessions: Bio-Sample Management – Best Practices, Challenges and Experiences; Compound Management's Added Value; Physical Lab Moves: Challenges and Best Practices; Innovation and Change Management; and Sustainability in Compound Management.
You can meet EU-OPENSCREEN in person in Toulouse: Martin Popr from our Czech partner site IMG and Geert Daudey from our Spanish partner site USC will attend the SLAS Compound Management Symposium and are interested in discussing with you about your experience and best practices in compound management.
For more information, please visit https://www.slas.org/events-calendar/slas-2024-sample-management-symposium/
You are kindly invited to this year's XVI Spanish Drug Discovery Network (SDDN) meeting, which will be hosted by our partner site Príncipe Felipe Research Center Foundation (CIPF) in Valencia. Scientific delegates from our Spanish partner sites will attend and are looking forward to meeting you in person.
Maria Jesus Vicent (CIPF) will moderate the Welcome and keynote session on Wednesday, November 13. Olga Genilloud (MEDINA Foundation) and Maria Jesus Vicent (CIPF) will moderate the Welcome and keynote session of EU-OPENSCREEN Director General Phil Gribbon on Thursday, November 14. Israel Ramos from our new screening partner site at the IRB Barcelona will moderate the Technologies in drug discovery I session on Thursday.
SDDN, the Spanish Association of Drug Discovery and Development Professionals provides discussion forums and collaborative frameworks to promote interactions between the public and private sectors to achieve greater efficiency in the discovery and preclinical development activities of new therapies in Spain. Several EU-OPENSCREEN partner sites are members of the SDDN Board of Directors, which is chaired by Olga Genilloud at our partner site Fundación MEDINA.
Learn more about the SDDN2024 at https://www.sddn.es/xvi-sddn-meeting-2024/.
The programme is available at https://www.sddn.es/programme2024/.
EU-OPENSCREEN co-organises the next International Helmholtz Drug Discovery Conference 2025 (HDDC2025) at the MDC.C in Berlin.
The focus of HDDC2025 is RNA as drug and drug target, Novel cardiovascular drugs, PROTACs, Artificial Intelligence in Drug Discovery, Chemoproteomics and much more. Scientists from academia and industry are invited to discuss the challenges and chances of modern drug discovery. Besides keynote presentations by internationally renowned speakers, oral and poster presentations selected from abstracts will allow participants to discuss their findings with expert peers. We also plan a session with start-up companies presenting their activities in drug research.
After the inclusion of the first chemoproteomics partner sites in the EU-OPENSCREEN consortium, a special workshop on chemoproteomics is organised by EU-OPENSCREEN on Monday, April 28th, at 10:30–12:30.
The conference flyer can be downloaded here: https://www.mdc-berlin.de/system/files/document/HDDC2025_Flyer_2.pdf
For more information, please visit https://www.mdc-berlin.de/de/HDDC2025
EU-OPENSCREEN organises the 9th edition of its biennial scientific meeting, the European Chemical Biology Symposium (ECBS) on October 6–9, 2025, at the Sorbonne Université in Paris, France.
Ten years after the ICBS/ECBS2015 in Berlin, the last joint meeting with the International Chemical Biology Society (ICBS), the ICBS returns to Europe.
The upcoming ICBS/ECBS2025 is jointly organised by EU-OPENSCREEN, the European Chemical Society (EuChemS Division of Chemistry in Life Sciences), International Chemical Biology Society (ICBS) and the Chemical Biology Division of the French Chemical Society (SCF-ChemBio).
The main theme of the ICBS/ECBS2025 is "Approaching biology through chemistry" and several exciting topics will be addressed during the sessions. The conference brings together though leaders in the field and young minds from the global chemical biology community will discuss new approached to addressing the unmet challenges in the interface of chemistry and biology.
The registration and abstract submission will open soon.
Meet EU-OPENSCREEN face-to-face at the upcoming ELRIG meeting in London, UK, 2–3 October 2024.
Our Lead Data Scientist Christopher Schmied will present a poster about our recently released Cell Painting data around the EU-OPENSCREEN Bioactive compounds and will update the community about the currently generated Cell Painting data based on the European Chemical Biology Library (ECBL): Morphological Profiling Datasets Based on EU-OPENSCREEN Compound Libraries. Poster Board number: 186
EU-OPENSCREEN's cell painting efforts are a collaboration with four partner institutions: Leibniz Research Institute for Molecular Pharmacology (FMP), Fundación MEDINA, IMTM Palacký University Olomouc and the University of Santiago de Compostela.
Our partner site the Latvian Institute of Organic Synthesis is also participating in this major event with its own stand, aiming to establish international contacts, foster collaboration, and showcase its technical capabilities and high-level expertise for projects and joint research ventures.
ELRIG Drug Discovery is Europe's largest conference for the drug discovery community. Scientific sessions include topics such as mechanisms of ageing and cell & gene therapy, but also more practical aspects of drug discovery encompassing advances in assay design, applications in high-content imaging, target identification and disease modelling.
For more information on the event please see here: https://elrig.org/portfolio/drug-discovery-2024/
Meet EU-OPENSCREEN at the XXVIII EFMC International Symposium on Medicinal Chemistry in Rome.
Our partner Ruth Brenk, University of Bergen, will present her research on 'Hit Discovery for Riboswitches as Targets for Antibiotics' during the 'Targeting RNA and RNA-Regulatory Proteins' session on Monday, September 2nd at 14:30-14:50.
During the 'New Technologies for the Discovery of Protein Degraders' session on Wednesday, September 4th, Johanna Huchting at our partner site Fraunhofer ITMP will talk about a 'Rationalized Screening Platform for Molecular Degrader Discovery'.
Carmen Gil at our partner site Centro de Investigaciones Biológicas (CSIC) in Madrid is a member of the 'International Scientific Committee'.
For more information, visit: www.efmc-ismc.org
EU-OPENSCREEN will join the French Medicinal Chemistry Society in Bordeaux, France on July 3-5, 2024 for the 58th edition of the International Conference on Medicinal Chemistry (RICT 2024).
The congress will be devoted to "Interfacing Chemical Biology and Drug Discovery". Our Analytical Chemist, Victoria Mora, will present the benefits of participating in the EU-OPENSCREEN compound sharing initiative.
For more information on the event please see here: https://www.rict2024.org/
Compound repurposing is an important strategy for the identification of effective drugs. EU-OPENSCREEN designed a compound collection of 2,464 known bioactives with high target selectivity against 1,039 different targets. This bioactives collection contains 654 approved drugs and 368 highly selective probes from the public domain. In addition, various drug repurposing collections are available for drug repurposing studies at our partner sites, including the most comprehensive and up-to-date biologically annotated collections of FDA-approved compounds based on the Drug Repurposing Hub and ReFRAME library.
EU-OPENSCREEN will give a talk on 5 July at the RExPO'24, the 3rd edition of the International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing, which is hosted by REPO4EU.
For more information, visit: https://repo4.eu/rexpo24/
The 48th FEBS Congress 'Mining biochemistry for human health and well-being' will focus on human health and well-being, through molecular and cellular science approaches. EU-OPENSCREEN, Instruct-ERIC, Euro-BioImaging and Infrafrontier will organise the Special Session "New opportunities for researchers – Research infrastructures in imaging, structural biology, human disease modelling and compound screening" at the upcoming 48th FEBS Congress 2024 on Monday, July 1st, 8:30-10:30 am in Milan, Italy. During this session, the four research infrastructures in chemical biology (EU-OPENSCREEN), structural biology (Instruct-ERIC), biological and biomedical imaging (Euro-BioImaging) and human disease modelling (INFRAFRONTIER) will present how scientists can work with these infrastructures to advance their research projects.
Jeanette Andersen from our partner site in Tromsø chairs the session on 'Marine biochemistry', together with our EMBRC colleague Donatella de Pascale, on Wednesday, July 3rd, at 14:00-16:00. Jeanette will talk about 'Anticancer compounds isolated from Arctic Marine organisms'.
For more information, visit: https://2024.febscongress.org/
Päivi Tammela from our screening partner site Institute for Molecular Medicine Finland (FIMM) will give a talk today on our EU-OPENSCREEN Academic Compound Library – "New opportunities for the chemistry community" at this year's Chemical Solutions for Biological Challenges (CSBC) Conference in Turku Finland. For more information and the full programme please see here: csbc2024.fi
The CSC2024 is the premier conference for the Canadian Society for Chemistry which aims to strengthen the Canadian and international chemical science community and to promote global perspectives and developments in chemical sciences and their role in solving global challenges.
EU-OPENSCREEN will give a talk "Putting community compounds to good use: An open compound sharing initiative" on 5 June during the "Molecular Tools for Discovery in Chemical Biology" session (Meeting Room 10). Chemists will learn about the benefits of sharing their compounds through EU-OPENSCREEN's compound sharing initiative to uncover the bioactivities of their compounds in a pre-competitive network of like-minded researchers and to strengthen closer collaborations between Canadian and European sciensts.
For more information, visit: https://www.cheminst.ca/conference/canadian-chemistry-conference-and-exhibition-csc-2024//
Our lead data scientist, Christopher Schmied, will present a poster to update about the recent and future developments in generating Cell Painting data around the EU-OPENSCREEN ERIC compound collections: Morphological profiling datasets based on EU-OPENSCREEN compound libraries.
The Society for Laboratory Automation and Screening (SLAS) is an international professional society of academic, industry and government researchers as well as developers and providers of laboratory automation technology and tools. Our Director General, Phil Gribbon, is the Vice President of the SLAS and will also be present in Barcelona. The Conference of the Society for Laboratory Automation and Screening (SLAS) is an important venue for research and development in early drug discovery. For more information please visit the event website: https://www.slas.org/events-calendar/slas-europe-2024-conference-and-exhibition/
Kathy Skopelitou, Coordination Manager scientific services, presents EU-OPENSCREEN and our services at the ProteoCure annual meeting May 7th-10th, 2024 in Warsaw, Poland. The meeting is organised by our Polish partner site IBB in Warsaw. The COST action ProteoCure aims at gathering European research teams and companies sharing the objective to develop new approaches and strategies to selectively manipulate protein fate for therapeutic or biotechnological purposes.
Join us on April 24 at 15:15 when our analytical chemist Victoria Mora will give a talk on "EU-OPENSCREEN: an open access initiative in chemical biology to support anti-cancer drug discovery". Victoria will introduce our compound sharing initiative and the numerous opportunities we offer to chemists to uncover novel bioactivities by adding their compounds to our unique academic compound collection.
On April 16-19, 2024, EU-OPENSCREEN, Drug Discovery and Development Centre (H3D) at the University of Cape Town and Fraunhofer ITMP organised a comprehensive in-person training workshop on preclinical drug discovery for early career sub-Saharan African scientists. 40 scientists (selected from among 140 submitted applications) from across sub-Saharan Africa and >10 tutors from South Africa, Zimbabwe, Ghana and Germany attended the workshop in Cape Town, South Africa.
The aim of the workshop was to teach the basic concepts of preclinical drug discovery research, facilitate practical, team-based sessions to reinforce key drug discovery concepts and build collaborative international, interdisciplinary networks between the workshop participants. The workshop combined theoretical and practical training in key aspects that relate to exploring the effects of chemical substances in biological assays. Live lab demonstrations were organized as part of local site visits to the H3D drug discovery laboratories.
We are grateful to the Volkswagen Stiftung which kindly supported the organisation of this workshop.
XV Spanish Drug Discovery Network (SDDN) Meeting
November 23-24, 2023, Barcelona, Spain
The Spanish Drug Discovery Network (SDDN) is the Association of Professionals for the Discovery and Development of New Therapies in Spain. SDDN members work both in academia and industry, and are dedicated to a wide spectrum of scientific and technical disciplines related to the discovery and preclinical development of new drugs. Over the last decade, all Spanish EU-OPENSCREEN partner sites are active members in the SDDN: Olga Genilloud (Fundación MEDINA), Mabel Loza (University of Santiago de Compostela), Maria Jesus Vincent (CIPF Valencia) and Ana Martinez (CSIC Madrid) are members of the SDDN Board of Directors.
Meet us at the next SDDN meeting in Barcelona. More information will be available soon
31st International Symposium on the Chemistry of Natural Products and the 11th International Congress on Biodiversity (ISCNP31 & ICOB11)
October 15-19, 2023, Naples, Italy
EU-OPENSCREEN will organise the satellite workshop “Accelerating Natural Product Discovery by academic and industrial collaborative initiatives” at the 31st International Symposium on the Chemistry of Natural Productsand the 11th International Congress on Biodiversity (ISCNP31 & ICOB11) on October 19 in Naples, Italy. The satellite workshop will be free to attend and will be held in the Auditorium Royal Continental.
Natural products continue to play an important role in drug discovery due to their molecular complexity and privileged structures. Nevertheless, only a fraction of reported scaffolds is available in commercial libraries and access to HTS-amenable libraries remains an important challenge. During our workshop, we will present various initiatives in academia and industry, which address this challenge. The speakers will present publicly available natural compound collections, local bioprospecting efforts and collaborative initiatives in Europe and Latin America, which aim to expand the availability of high quality, annotated natural product-based libraries for drug discovery projects.
The preliminary programme is available on the conference website: www.iscnp31-icob11.org
XIII European Congress on Marine Natural Products (ECMNP) & XVII International Symposium on Marine Natural Products (MaNaPro2023)
September 3-8, 2023, Granada, Spain
Three years after the last XVI MaNaPro & XI ECMNP meeting in 2019 in Portugal, our partners at Fundación MEDINA in Granada invite you to this year’s XIII European Congress on Marine Natural Products and XVII International Symposium on Marine Natural Products joint meeting in Granada, Spain, on September 3-8, 2023.
The conference program will cover the following topics: Chemical Ecology and Ecosystems Functioning; Natural Products Isolation and Structural Elucidation; Drug Discovery and Development; Synthesis of Marina Natural Products and Medicinal Chemistry; Structural Methods in Marina Natural Products research; Marina Natural Products Chemical Biology and Biotechnology; Genomic tools in Marina Natural Products Discovery; Metabolomics, Artificial Intelligence and Machine Learning applied to Marina Natural Products research.
Abstracts can be submitted until 15 May 2023. The early registration deadline is 30 June 2023. More information is available at: www.ecmnp-manapro2023.com/index
Natural Products – Emerging opportunities
July 18-19, Swansea, UK
This is a networking event, Led by the Natural Products BioHUB in Swansea, to establish consortia of interdisciplinary expertise and innovative tools to fast track the research translation to the development of novel products and services. The event offers a unique opportunity to explore opportunities for natural product development in pharmaceuticals, cosmeceuticals, and the food industry.
The event focusses on the following key themes:
• Bioprospecting for new bioactive molecules from underexploited aquatic and terrestrial sources
• Extraction, purification & structure elucidation of bioactive compounds
• Current & future platforms for biodiscovery and bioactivity screening
• Computational modelling and artificial intelligence approaches for natural product research
• Animal and non-animal testing systems
• Formulation & application technologies
• Success stories (Start-Ups & collaborative Networks)
Our EU-OPENSCREEN partners Jeanette Anderson (UiT, Norway) and Olga Genilloud (Medina, Spain) will give oral presentations on Tuesday, 18 July. Jeanette will present 'Marine Bioprospecting in the Arctic and the value of participating in EU Projects and Initiatives' and Olga will highlight 'Fundación MEDINA: Fostering natural products bioprospecting and drug discovery collaborations'.
EU-OPENSCREEN organises the workshop 'Accelerating Chemical Biology and early Drug Discovery by academic collaborative initiatives' at the 19th World Congress of Basic and Clinical Pharmacology 2023 (WCP2023) on 3 July 2023 in Glasgow, UK.
Over the past years, a variety of consortia with different collaborative models have been initiated, which bring together academic groups and industry partners to develop novel chemical tool compounds. During this workshop, we will present how collaborative initiatives such as EU-OPENSCREEN can support chemical biology and early drug discovery projects in academia. We will discuss different models and highlight successful case studies to illustrate the opportunities that are available for the scientific community.
The speakers of this session are: Prof. Graeme Milligan (University of Glasgow United Kingdom), Prof. Matthew Todd (University College London), Prof. Päivi Tammela (University of Helsinki), Prof. Mabel Loza (University of Santiago de Compostela), Elisa Sassetti (Danmarks Tekniske Universitet Denmark) and Bahne Stechmann (EU-OPENSCREEN). For more information on this session, please visit: https://wcp2023.org/events/accelerating-chemical-biology-and-early-drug-discovery-by-academic-collaborative-initiatives/ or visit the official WCP2023 website: https://wcp2023.org/
Nordic Natural Products Conference (NNPC2023)
June 14-16, 2023, Helsinki, Finland
Prof Päivi Tammela at our partner site Helsinki University organises this year’s Nordic Natural Products Conference (NNPC2023). The Nordic Natural Products Conference strengthens the Nordic scientific collaboration in the field of natural product chemistry, pharmacognosy and closely related disciplines. The scientific programme of NNPC2023 showcases the interdisciplinarity of natural product research and a range of topics and newest advances are covered by prominent speakers. NNPC2023 is also a great opportunity for presenting your latest results to the scientific community and for networking with colleagues from the Nordic countries and beyond.
Join us in Helsinki to discuss various topics, including Natural product analytics, Sustainable sourcing in natural product drug discovery, New sources for natural product discoveries, New targets and biological activities for natural products, Ethnopharmacology and traditional medicine, and Natural product research - From the past to the future.
The history of Nordic Natural Products Conference (NNPC) dates back to 1961 when it was organised for the first time in Bornholm, Denmark, as Nordic Natural Product Chemistry Symposia. Since 2005, the meeting has been arranged every second year in one of the Nordic countries. In 2021, the NNPC was held in virtual format due to the Covid-19 pandemic, but now we hope to meet again in person in 2023, this time in Finland.
Abstract submission closes April 15 and registration is open until June 1. More information on NNPC is available here: www.helsinki.fi/en/conferences/nordic-natural-products-conference-2023
ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023
June 10-13, 2023, Boston, USA
The ACSMEDI | EFMC Medicinal Chemistry Frontiers is co-organised as a collaboration between the ACS (American Chemical Society) MEDI (Division of Medicinal Chemistry) and the EFMC (European Federation for Medicinal chemistry and Chemical biology). The ACSMEDI | EFMC Medicinal Chemistry Frontiers Meeting attracts a highly targeted audience composed of experts, researchers and early career trainees in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, and early toxicology.
Prof. Rui Moreira at our EU-OPENSCREEN partner site at University of Lisbon and EFMC President, is a member of the Scientific Organizing Committee and chairs the session on Organic Synthesis Impacting Medicinal Chemistry & Chemical Biology.
We hope to meet you at ACSMEDI-EFMC Medicinal Chemistry Frontiers 2023.
More information available at: https://www.medchemfrontiers.org/
International Helmholtz Drug Discovery Conference (HDDC 2023)
May 15-16, 2023, Braunschweig, Germany
Prof Mark Brönstrup and his colleagues at our German partner site HZI Helmholtz Centre for Infection Research in Braunschweig organise another edition of the International Helmholtz Drug Discovery Conference. A satellite workshop on Drug Repurposing will be organised by our colleague Phil Gribbon at Fraunhofer ITMP on Monday, May 15th (morning).
The HDDC2023 will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and scientists from biotech and pharmaceutical industries. With topics focusing on anti-infectives, innovative screens, novel targets and target validation, computational approaches incl. artificial intelligence (AI) and more, this event will be an excellent opportunity to discuss the challenges and chances of modern drug discovery in academia and industry. In order to foster interaction and knowledge gain in the field, we are pleased to welcome an exceptional group of internationally renowned speakers.
Abstracts for oral and poster presentation can be submitted by April 1, 2023. Registrations are open until May 1, 2023. More information can be found here: www.helmholtz-hzi.de/en/news-events/events/view/event/info/hddc-2023-1/
Our biennial flagship scientific conference, the European Chemical Biology Symposium (ECBS) brings together Chemical Biologists from all parts of Europe and overseas to present and discuss the latest achievements in cutting edge chemical sciences. The ECBS is jointly organised every two years by EU-OPENSCREEN and the EuChemS Division of Chemistry for Life Sciences.
The 8th edition of the ECBS (ECBS2023) will be held on May 9-11, 2023, at the AstraZeneca R&D site in Gothenburg, Sweden, as a combined event with the inaugural ELRIG meeting on Therapeutic OLIGOs. The conference will focus on exciting topics like Therapeutic OLIGO profiling, Advancements in OLIGO design and synthesis, Novel formulations and biomarker analysis, Chemical probe-induced protein interaction and degradation, New ways to shape and interrogate biology through chemistry, and Innovative tools and methods for advanced cell profiling.
Detailed information and free registration: www.ecbs2023.eu
AACR Annual Meeting 2023
April 14-19, 2023, Orlando, USA
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
Meet us at the EU-OPENSCREEN poster on April 18, in the Poster Session PO.CH01.05 - High-throughput Screening, Lead Identification and Optimization, and in Silico Drug Discovery.
More information is available at: https://www.abstractsonline.com/pp8/#!/10828/presentation/5253
BIOPROSP is a biennial International Conference on Marine Biotechnology and Bioprospecting, which is co-organised by our scientific partner Prof. Jeanette Andersen at UiT - The Arctic University of Norway in Tromsø. BIOPROSP is an exciting and rewarding conference for researchers and representatives from both research institutions and enterprises.
EU-OPENSCREEN organises pre-conference workshop at Bioprosp_23, which is chaired by Jeanette Andersen (University of Tromsø) and Bahne Stechmann (EU-OPENSCREEN). During the workshop, we will discuss how publicly available repositories, local bioprospecting efforts and research infrastructures can help expand the availability of high quality, well annotated natural product-based libraries for screening. Our speakers will present publicly available resources in Europe, which are available to the research community; local efforts in bioprospecting and creating local collections; and collaborative initiatives to expose natural compounds to a broad range of biological targets in screening efforts.
For more information, please visit the event website: https://www.tekna.no/en/events/bioprosp_23-42323/Info/?info=172805
After the last edition in 2018, the biennial SACI National Convention is finally back as an in-person meeting. The theme of the upcoming 44th South African Chemical Institute's National Convention is “Chemistry for sustainable development in Africa”.
500 registered attendees (sold-out) will discuss how chemists can deliver solutions that will further the sustainable development of the African continent. From clean water to combatting diseases, from novel materials to new technologies, from natural resources to cutting edge science, chemists will explore how to best keep moving forward with our sustainable development goals.
As an open-access research infrastructure, EU-OPENSCREEN offers chemists a platform to collaboratively implement discovery projects to identify and develop new therapeutic solutions in numerous disease areas with focus on those threatening the progress in global health. During his oral presentation, Bahne Stechmann, Head of Operations & Scientific Strategy will present the opportunities for African scientists offered by EU-OPENSCREEN.
Detailed information: https://www.saci.co.za/SACI2023/
Chemists in Latin America are invited to submit compounds to EU-OPENSCREEN, and by doing so, making them available to other biologists with the ambition to uncover the hidden bioactivities of their compounds.
Dr Ana Martinez, our medicinal chemistry partner at CSIC Madrid, will give a presentation at the next annual meeting of the Sociedad de Farmacología de Chile (SOFARCHI) on December 5-9, 2022 in Punta Arenas, Chile. Ana will present her work on “Pharmacologic modulation of TDP-43, a new future for neurodegeneration therapy.”
More information and registration can be found here: https://www.sofarchi.cl/conferencistas-y-simposios-xliii-congreso-anual-de-la-sociedad-de-farmacologia-de-chile-2/
The 11th annual conference of the International Chemical Biology Society (ICBS) will take place this December 4-7 in Brisbane, Australia. Venturing south of the equator for the first time, ICBS 2022 is located at the Brisbane Convention & Exhibition Centre and hosted by the Institute for Molecular Bioscience at The University of Queensland.
ICBS 2022 will centre on the theme of “Uncovering solutions for diseases” with a focus on academic and industrial applications of chemical biology to both fundamental and translational research. ICBS 2022 will encompass not only human health, but also include investigations into agricultural and environmental diseases. If you attend the ICBS 2022, meet us at the EU-OPENSCREEN poster during the poster session on Monday/Tuesday Dec 5-6.
For more information, please visit the ICBS 2022 website: https://icbs2022.chemical-biology.org/
The Spanish Drug Discovery Network (SDDN) is the Association of Professionals for the Discovery and Development of New Therapies in Spain. SDDN members work both in academia and industry, and are dedicated to a wide spectrum of scientific and technical disciplines related to the discovery and preclinical development of new drugs. Over the last decade, all Spanish EU-OPENSCREEN partner sites are active members in the SDDN: Olga Genilloud (Fundación MEDINA), Mabel Loza (University of Santiago de Compostela), Maria Jesus Vincent (CIPF Valencia) and Ana Martinez (CSIC Madrid) are members of the SDDN Board of Directors.
Meet us at the XIV SDDN meeting in Granada and join the lively discussions about Nucleic Acids as Therapeutic Agents, Drug Discovery in Spain, Targeted Protein Degradation, Antimicrobial Resistance and New Antibiotics, and Biologics in Drug Discovery and Development.
More information about the XIV SDDN Meeting: http://www.sddn.es/xiv-sddn-meeting/
Following the 1st National Library of Chemical Compounds (KBZCh) POL-OPENSCREEN Workshop, which took place in June this year, Zbigniew J. Leśnikowski, Coordinator POL-OPENSCREEN, and his team are pleased to welcome you to the 2nd POL-OPENSCREEN Workshop. We hope that the workshop will foster the integration of a community of both chemists and biologists in Poland in their search for novel bioactive compounds for various areas of the life sciences.
KBZCh provides the possibility of free deposition of chemical compounds synthesised in national laboratories (universities, institutes, research laboratories, others) for the needs of various research projects and their "repurposing" by making them available to interested entities, both Polish and foreign, for biological screening studies in order to search for new bioactive compounds and other scientific research. KBZCh is the first compound bank of its kind in the country, providing, on a non-commercial basis, biologists with access to unique chemical libraries and chemists with opportunities to test synthesised compounds and generate added value through wider use of compounds obtained in Polish laboratories. Data collected in KBZCh are available for interested scientific institutions and industry on an agreed rules protecting the intellectual property of the interested parties.
The workshop is organised jointly with the Medical University of Lodz on the BRain campus. For interested attendees, a site visit to the KBZCh facilities at IBM PAN will be organised.
More information about KBZCh can be found on the POL-OPENSCREEN website: www.pol-openscreen.pl.
ICRI will provide a platform for high-level debates of research infrastructure policymakers, operators and users, and research stakeholders from around the world to address the most pressing research infrastructure topics.
Scientific research is global in nature, and international cooperation in research and public health is crucial to minimise loss of life and impact on global health and the global economy. Geographical diversity in climate, ecosystems and disease prevalence also provides a key motivator for international collaboration involving research infrastructures to maximise scientific discovery. We co-organise the ICRI 2022 Side Event on 'International Cooperation of Research Infrastructures: Building on the outcomes of the RI-VIS Project' on October 19, 19:00-21:30. This event builds on the outcomes of the recently concluded RI-VIS project to address challenges in the international cooperation of research infrastructures.
EU-OPENSCREEN is a project partner in ISIDORe, a new initiative to advance epidemic preparedness and response research in Europe. It assembles and provides access to an unprecedented One Health driven integrated portfolio of cutting-edge research resources, dedicated to the study of any epidemic-prone diseases. Join us to learn more about ISIDORe during the hybrid site event on October 19, 9:30-12:00. Our Director General, Wolfgang Fecke, will be a speaker during this session and represent EU-OPENSCREEN, which leads the Therapeutic development work package.
The ERIC Forum organises the site event “Research Infrastructures’ Contribution to SDGs: Enabling Excellent Science in Service of Society” on October 19, 19:00-20:30, which brings together policy makers, Research Infrastructures and the general public to raise awareness about Research Infrastructures’ role and contribution to the attainment of the Sustainable Development Goals.
Virtual registration to the ICIR site events is still available: https://icri2022.gcon.me/registration/3-registration-to-attend-the-side-events-of-icri-2022
The Brazilian Symposium on Medicinal Chemistry (BrazMedChem) is the largest scientific Medicinal Chemistry conference in Latin America. The scientific program covers a diversity of topics in drug discovery and development. 20 years after the first BrazMedChem symposium in 2001, the theme of this year's symposium is "Twenty years making science for the society."
Our medicinal chemistry partner Dr Ana Martinez at CSIC Madrid will give a presentation entitled "From the theory to the bench in multitarget drugs for Alzheimer’s disease therapy" on Wednesday, September 28th, during the "Multi-target Directed Ligands" session. Dr Bahne Stechmann, EU-OPENSCREEN, will present a poster about EU-OPENSCREEN's compound submission model, by which chemists can share their compounds in a regulated, transparent model to search for novel bioactivities of their compounds.
If you attend the BrazMedChem2022, do not hesitate to reach out and talk with Ana and Bahne.
More information and registration can be found here:
Our Latvian partner site, the Latvian Institute of Organic Synthesis is organising the 2nd Drug Discovery Conference, which will take place in Riga, Latvia from September 22-24 in 2022. The conference speakers will cover modern trends in drug discovery related to organic synthesis, medicinal chemistry, pharmacology, structural biology, and drug delivery.
EU-OPENSCREEN staff, Victoria Mora and Tanja Miletic will present posters entitled “Identify new biological activities of your compounds” and “Accelerating small molecule drug discovery by a powerful collaborative approach”, respectively. Attendees will have the chance to learn more about the EU-OPENSCREEN's compound submission model and how to access the EU-OPENSCREEN compounds libraries and its services with focus on fragment screening.
More information and registration can be found here.
September 4-8th, 2022 Nice (France)
Our Spanish partner Prof. Ana Martinez from CSIC Madrid will present 'New Treatments for Current and Future Pandemics' at the next EFMC-ISMC 2022: XXVII EFMC International Symposium on Medicinal Chemistry. Ana's presentation will be part of the open session on 'Drug Discovery Projects'.
The EFMC-ISMC 2022 will be held as an in-person event in Nice, France on 4-8 September 2022. The symposium will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer.
For more information, visit the official symposium website: https://www.efmc-ismc.org/
The 8th EuChemS Chemistry Congress, organised by the Portuguese Chemical Society (SPQ), focusses on the central role of chemistry at the interfaces with biology, material and environmental sciences, both for the progress of humankind and for the solution of fundamental problems of modern societies. The congress features sessions on Chemical Biology (Theme C: Chemistry Meets Biology), Drug Design and Discovery, and Drug Delivery (Theme E: Biomaterial and Medicincal Chemistry). If you plan to attend the EuChemS Chemistry Congress, come and meet EU-OPENSCREEN in Lisbon.
You can find more information on the event here: https://euchems2022.eu/
The 70th International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research (GA) aims at expanding our current knowledge on all aspects of natural product research, and brings together renowned international scientists. After the Covid-19 pandemic, the congress will be held as face-to-face meeting in Thessaloniki. Olga Genilloud Scientific Director of our partner site Fundación MEDINA in Granada is a keynote speaker at the congress and will present the "Challenges and opportunities in anti-infective discovery from microbial natural products" on Tuesday, August 30th at 11:30-12:00.
You can find more information on the event here: ga2022.web.auth.gr
The Chemical Biology Ireland Conference (ChemBioIreland2022) will take place at the University College Dublin on August 8-9, 2022. This two-days conference covers topics from protein, carbohydrate, and nucleotides chemistry broadly defined, ranging from synthetic methodology to translational applications. If you attend the ChemBioIreland2022, come and meet Bahne Stechmann, EU-OPENSCREEN Head of Operations & Scientific Strategy.
Registration and more information on the event here: https://sites.google.com/view/chembioireland2020/home
The MMCS2022 is the third edition of the Molecules Medicinal Chemistry Symposium series. The thematic sessions cover molecules against drug resistant microorganisms and SARS-CoV-2, targeted protein degradation, machine learning approaches, natural compounds, multitarget drug discovery and medicinal chemistry success stories. Meet Bahne Stechmann at the MMCS2022, who he will present EU-OPENSCREEN during the poster session.
You can find more information on the event here: https://mmcs2022.sciforum.net/
Meet EU-OPENSCREEN at the Mannheim University of Applied Sciences. Exciting lectures and news on the topics of Innovative Compound Profiling Technologies and Assays (MassSpec Assays and 4D-Microscopy of 3D-Cultures) and Process Chemistry and Analysis await you over two days. The full programme is available here.
Register here until June 1, 2022
Our Spanish partner Prof. Mabel Loza from the University of Santiago de Compostela will present EU-OPENSCREEN and other collaborative & translational initiatives at the upcoming XX National Meeting of the Spanish Society of Medicinal Chemistry (SEQT2022). The theme of the SEQT2022 is 'From Early Discovery to Translational Medicinal Chemistry'. The meeting will be held as an in-person event in Santiago de Compostela on 23-26 January 2022.
For more information, visit the official conference website: https://congresoseqt2022.es/
Our General Director, Wolfgang Fecke, will present EU-OPENSCREEN at Future Labs Live in Basel.
EU-OPENSCREEN Director Wolfgang Fecke will present the EU-OPENSCREEN European Chemical Biology Database (ECBD) and highlight how the wide availability of the data to everyone will help scientists to identify novel chemical probes and develop better data-driven computational prediction tools.The ECBD is the central data hub for data generated within the EU-OPENSCREEN network. All structures and primary screening data are made available. Experimentally measured physicochemical and biological data on compound properties such as solubility, light absorption, cytotoxicity or anti-microbial activity are now also being uploaded into the ECBD. The addition of cell painting data for these compounds might aid in the elucidation of their molecular mechanisms and identification of biological targets when they are identified as promising hits in phenotypic assays.
More information on the event can be found here:https://www.slas.org/events-calendar/slas-europe-2022-conference-and-exhibition/
Meet our EU-OPENSCREEN Scandinavian partners Johannes Landskron UiO Oslo, Luca Laraia DTU Denmark, Päivi Tammela FIMM Finland, Anna-Lena Gustavsson KI Sweden, Brinton Seashore-Ludlow KI Sweden, who are co-organisers and speakers of this meeting to discuss current and future formats for cell based assays .The fourth ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held on May 10-12 at the AstraZeneca R&D site in Gothenburg. For more information and registration please see here.
Bruker, M2Aind and CeMOS – Center for Mass Spectrometry and Optical Spectroscopy are organising the European Pharma Days on April 27-28th 2022: this 2-day event will focus on advanced MS based technologies like trapped ion mobility and MALDI Imaging and how these new technologies are transforming drug discovery. Applications within biologics characterization (day 1) and MALDI Imaging (day 2) will be covered.
EU-OPENSCREEN has a high interest in developing high throughput mass spec methods together Carsten Hopf from CeMOS and industrial partners such as Bruker. Therefore, definitely don't miss the talk of our EU-OPENSCREEN-DRIVE partner Carsten Hopf, who is working at the CeMOS – Center for Mass Spectrometry and Optical Spectroscopy at the Hochschule Mannheim (Germany) on topics such as MALDI Imaging MS, MALDI MS Assays, Mass spectrometry applications in pharma and biopharma industry, Biomarker Discovery and Drug Discovery:
14:00 - 14:30 Multimodal MALDI Imaging
Prof. Dr. Carsten Hopf, Center for Mass Spectrometry and Optical Spectroscopy (CeMOS), Mannheim, Germany
EU-OPENSCREEN ERIC is currently enlarging the service portfolio to chemoproteomics: Carsten is also involved in our EU-OPENSCREEN-DRIVE chemoproteomics and MSI open call and implements user projects.
Read more about the European Pharma Days 2022 here.
The Faculty of Pharmaceutical Sciences of the Chulalongkorn University in Thailand organises the 37th edition of the International Meeting in Pharmaceutical Sciences (IAMPS37). This international meeting will take place via an online platform (ZOOM Webinar) on March 24-25, 2022.
This annual conference has been organised since 1982 with the purpose of giving an opportunity for academics, scientists, researchers, graduate students, etc. from various institutes to communicate and share their works, knowledge, and experiences. There will be a series of keynote presentations, oral and poster sessions regarding three areas: 1) Pharmaceutical chemistry and natural products; 2) Pharmaceutical technology and biopharmaceutical sciences; and 3) Clinical and social/administrative pharmacy.
Bahne Stechmann will give the plenary lecture on EU-OPENSCREEN - A collaborative model for accelerating early drug discovery at 11:30-12:00 local time (5:30-6:00 am CET).
For more information on this international meeting, please visit the conference website: http://cu-amps.weebly.com/
Are you looking for an open access compound library to perform high throughput screening (HTS)?
If your drug discovery project is at a stage in which you need to identify hits and optimise them, then you will be searching for the optimal compound libraries and HTS platforms. In this SPARK Europe Webinar our former Interim Lab Automation Manager, Dr. Edgar Specker, a medicinal chemist (Bayer, Zedira , Jerini ) with over 10 years of experience as compound library manager will present and explain the compound libraries and the screening services of EU OPENSCREEN. Do not miss this opportunity to learn more on our service offer. Free registration is open until Feb 1st, 2022, here.
The virtual 'Europe-Russian Federation Symposium on Research Infrastructures' brings together delegates from Russian and European Research Infrastructures (RIs), which are active in different scientific domains, to raise awareness of the broad array of scientific opportunities offered to scientists and for RI cooperation between Europe and the Russian Federation. Bahne Stechmann will present how Russian researchers can work with EU-OPENSCREEN partner sites to collaboratively develop novel chemical probes and how Russian chemists can make their compounds available to other researchers to identify novel bioactivities of these compounds. Any researchers who has an interest in learning more about RIs and the research opportunities they offer to scientists is cordially invited. This symposium is organised by RI-VIS and CREMLINplus.
For free registration and additional information (e.g. agenda, speakers), visit the symposium website: https://indico.desy.de/event/32535/
Katholiki Skopelitou, EU-OPENSCREEN Coordination Manager Scientific Services, will give a talk on "EU-OPENSCREEN:Bridging science and technology for chemical biology and early drug discovery all across Europe"
Webinar with Ctibor Škuta from EU-OPENSCREEN database partner site IMG in Prague on the "Resource landscape for chemical probes".
Ctibor Škuta and his team from IMG in Prague have developed EU-OPENSCREEN’s novel European Chemical Biology Database (ECBD) of chemical and biological screening data: https://ecbd.eu/. Registration and more information: https://www.target2035.net/upcoming-webinar
EU-OPENSCREEN, Instruct and Euro-BioImaging jointly organise a live networking session on "Training at International Research Infrastructures - Case studies in bio-imaging, structural biology and early drug discovery" at the upcoming CellBio Virtual 2021 meeting. The CellBio2021 is organised by EMBO and the American Society for Cell Biology (ASCB).
This interactive session will be a unique opportunity for international scientists and early career-scientists to learn more about the training opportunities that are provided by research infrastructures and how they can gain a competitive edge by working with research infrastructures in biological and medical imaging (Euro-BioImaging), structural biology (Instruct) and chemical biology (EU-OPENSCREEN).
Registration and more information on the event here: https://www.ascb.org/cellbio2021/
EU-OPENSCREEN is a very good example for this year’s focus of the ICBS which will highlight the impact of collaborations and partnerships to advance chemical biology. Bahne Stechmann, EU-OPENSCREEN Head of Operations and Scientific Strategy, will present how EU-OPENSCREEN has successfully established a European Research Infrastructure and is advancing and supporting research through collaborations in the field of Chemical Biology. Join us at the opening session on "Global advances in chemical biology" on Thursday, November 11th, 9:45-11:00 AM EST (15:45-17:00 CEST).For more information on the event please see the event website here.
Our Scientific Project and Industry Liaison Manager Robert Harmel will represent EU-OPENSCREEN at Discovery UK in London. Get in touch with him to learn more about possible collaboration options. More info here.
Bahne Stechmann, EU-OPENSCREEN Head of Operations & Scientific Strategy, will represent EU-OPENSCREEN at the virtual Australia- Europe Symposium on Research Infrastructures. He will be open for discussions with potential partners from Australia wishing to collaborate with EU-OPENSCREEN. For more information on the event please see here.
Our Director, Wolfgang Fecke, our Laboratory Automation Manager Sohie Brusseau and our Analytical Chemist, Victoria Mora, will present EU-OPENSCREEN´s central compound management facility at this year´s SLAS conference in Berlin. They will explain our laboratory automation system and our comprehensive and unique EU-OPENSCREEN compound collections. Interested scientists are welcome to discuss collaboration options with us. For more information please see here.
The biennial EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer. Visit EU-OPENSCREEN and discuss with us at our virtual booth.
More information: https://www.efmc-ismc.org/confirmed-exhibitors
This year, the annual congress of the Federation of European Biochemical Societies (FEBS) will be a virtual event and is entitled 'Molecules of Life: Towards New Horizons'. Join our EU-OPENSCREEN presentation during the 'Meet the expert session' and visit us at our virtual booth. We share our booth with other research infrastructures in structural biology (Instruct), biological and medical imaging (Euro-BioImaging), and biobanks (BBMRI).
More information: https://2021.febscongress.org/
Victoria Mora, Analytical Chemist at EU-OPENSCREEN, will give a talk on "OPPORTUNITIES TO IDENTIFY NEW BIOLOGICAL ACTIVITIES OF ACADEMIC COMPOUNDS" at this year´s ESOC virtual mini symposium. For more information please visit the event website.
The SLAS Europe 2021 Digital Conference and Exhibition: Connecting People. Advancing Science will focus on how automation can improve your laboratory's efficiency or how to better use the data from your automated processes. You can meet Phil Gribbon, Assistant Head of Deaprtment at our partner site Fraunhofer ITMP Hamburg, during the 'Academic Drug Discovery Special Interest Group (SIG)' session on Wednesday, June 23, 13:00-13:30 CEST. You can also watch Bahne Stechmann's presentation on EU-OPENSCREEN as part of the pre-conference 'SLAS Career and Business Showcase' session on Wednesday, 16-June-2021 from 16:00 to 18:00 CEST.For more information please visit the event website.
ADTCA 2021 brings together groundbreaking Data Technologies, and derived products and services which have the potential to greatly influence the global curbing of Antimicrobial resistance (AMR). Wolfgang Fecke, General Director of EU-OPENSCREEN, will give a talk on “Open data for discovery of novel antibiotics”. For more information please visit the event website.
The virtual three-day symposium co-organised by EU-OPENSCREEN within the RI-VIS project brings together delegates from Latin American and European research infrastructures (RIs), science policy organisations and research institutions to discuss opportunities and challenges for RI cooperations between Latin America and Europe. On June 16 at 10:30 CEST Bahne Stechmann will present EU-OPENSCREEN in the session on "Expanding Latin-American- European Partnerships". For more information and registration see here.
The International Conference on Research Infrastructures (ICRI) brings together policy experts, facility managers, leading researchers and a variety of other stakeholders to discuss challenges and emerging trends for research infrastructures around the world.
EU-OPENSCREEN has been chosen to present its COVID-19 related services in the response to the pandemic section. For more information on the ICRI 2021 conference see here.
For free registration and abstract submission please visit the event website: https://ecbs2021.eu/
The biennial European Chemical Biology Symposium (ECBS) is jointly organised by EU-OPENSCREEN and the EuChemS Division of Chemistry for Life Sciences and will be held as a virtual meeting on May 26-28, 2021. .
The ECBS 2021 will bring together scientists from Europe and overseas to present and discuss their latest achievements in cutting edge chemical sciences, ranging from small molecule targeting nucleic acids, targeted protein degradation via PROTACs or molecular glues, artificial intelligence in drug design, new antiviral therapies, natural products, protein aggregation, glycochemistry & -biology and nanostructured material for biology and medicine.
We encourage young researchers to present their work at the meeting (oral & flash presentations will be selected from submitted abstracts), discuss with the speakers and embrace the exciting developments currently happening in chemical biology.
The HDDC 2021 is co-hosted by Prof. Dr. Mark Brönstrup from our partner site Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany. Two afternoons (mornings in the US) will focus on two of today’s hottest topics in drug discovery: 'Proteolysis-targeting chimeras (PROTACs) - a new drug discovery paradigm?' and 'Novel treatment options against SARS-CoV-2'.
The conference provides a stimulating platform to discuss the state of the art in drug discovery with academic experts and scientists from biotech and pharmaceutical industries. An exceptional group of internationally renowned speakers will foster interaction and knowledge gain in the field. Due to the pandemic situation the HDDC 2021 is organised in a virtual and shortened format.
The conference is free of charge.
For further information and registration see here
The Research Infrastructures (RIs) in Biomedical Sciences (EATRIS, ECRIN, EU-OPENSCREEN, ELIXIR, INFRAFRONTIER and INSTRUCT), with the support of the Ministry of Science, are organising a national conference in Spain on Wednesday 10 March to discuss with the Spanish research community. We will inform about what RIs are, the role we will play in the Horizon Europe programme, and the services we can offer to researchers.
BIOPROSP_21 is the 10th biennial International Conference on Marine Biotechnology and bioprospecting, which is co-organised by our scientific partner Prof. Jeanette Andersen at UiT- The Arctic University of Norway in Tromso. BIOPROSP is an exciting and rewarding conference for researchers and representatives from both research institutions and enterprises. This year, BIOPROSP_21 is a brief, but inspiring and useful (and affordable) digital experience! The scientific conference will cover topics ranging from 'Accessing Biodiversity' and 'Tools for Marine Bioprospecting' to 'Scale-up and Industrialization' and 'Success stories'. For more information please visit the event website.
Feb 10, 13:45 CET: Phil Gribbon and Andrea Zaliani from our Fraunhofer ITMP partner site in Hamburg will give a talk on "Systematic variability in the results from community wide SARS-CoV-2 drug repurposing studies: the influence of cell model and library selection on hit populations"
For the agenda and free registration please see here
Research Infrastructures (RIs), science policy organisations and research institutions meet to discuss opportunities and challenges for RI cooperations between Africa and Europe. If you would like to know more about EU-OPENSCREEN´s range of services, do not miss the talk of Bahne Stechmann, EU-OPENSCREEN Head of Operations and Scientific Strategy, on February 1, 2021 at 1:15-1:30 p.m.
We hope to raise awareness of individual RIs, to identify measures to mitigate current challenges of biregional cooperations between RIs, to initiate new and strengthening existing collaborations, and to initiate networks in a sustainable way so that all stakeholders benefit. We invite all researchers who have an interest in learning more about Research Infrastructures and the research opportunities they offer to scientists. Participation in this event is for free, but registration is required.
This symposium is organised as part of the RI-VIS project, a Horizon 2020-funded project to increase the visibility and raise awareness of European RIs to new communities beyond Europe.
More information and registration on the event website.
EU-OPENSCREEN and Euro-BioImaging will organise the joint session “How to benefit from integrating international research infrastructures in your research project” at the upcoming Cell Bio Virtual 2020 Meeting, which is organised by ASCB and EMBO. This interactive session will be a unique opportunity for international scientists to learn how researchers can gain a competitive edge by working with research infrastructures in biological and medical imaging (Euro-BioImaging), and high-throughput screening (EU-OPENSCREEN). Different funding options will be presented.
Learn more about the event: here
Do not miss the opportunity to talk to our Director Wolfgang Fecke and our Scientific Project Manager Alessandra Silvestri at the 1st ENRIITC Virtual Networking Meeting to learn more on how EU-OPENSCREEN can accelerate your research in drug discovery, register here.
EU-OPENSCREEN Director Wolfgang Fecke will give a presentation on the access and operational model of EU-OPENSCREEN on Oct 13, 2020 at the Bioorganic Chemistry research group of Prof Wessjohann at the Leibniz Institute of Plant Biochemistry in Halle, Germany. The aim of the meeting is to discuss collaborations and joint grant applications in the field of plant-based natural products.
EU-OPENSCREEN Director Wolfgang Fecke will give a key note on "Tool compounds and drug candidates from the European chemical biology infrastructure EU-OPENSCREEN" at the 6th virtual “Drug Discovery Strategic Summit (DDSS). The Drug Discovery Strategic Summit highlights the advances in current and emerging hot targets and technologies, as well as target validation strategies for the discovery and development from biologics to small molecules. For more information and registration see here.
The INFRAFRONTIER Conference 2020 ‘Targeting Cancer with Animal Models’ will showcase innovative animal models used in cancer research and also introduce the Cancer Mission Board to the cancer research community. During the Session 3 - European Cancer Research Policy, on October 8th, 13:00-16:00 CET, Bahne Stechmann will present EU-OPENSCREEN and explain how EU-OPENSCREEN will contribute to the Cancer Mission under the new Horizon Europe framework programme. Example cancer research projects from our partner sites will illustrate how EU-OPENSCREEN and its partner sites help advance our understanding of cancer, identify novel cancer targets and contribute to the development of novel treatments.
For more information and registration please see here
Join us at the Biotech Atelier Virtual Conference and learn what EU-OPENSCREEN and other research infrastructures can offer to you. The agenda includes talks on the importance, the current role and the future of research infrastructures. Our Head of Operations and Scientific Strategy, Bahne Stechmann, will explain our portfolio of services with special focus on COVID-19. Registration and more information can be found here.
Learn more about EU-OPENSCREEN at the EFMC-ISMC Virtual Event 2020, a 2-days Virtual Event will take place on September 7-8, 2020. You can meet EU-OPENSCREEN and discuss with Bahne Stechmann, Head of Operations & Scientific Strategy, via Zoom on Tuesday, September 8, at 12:10 CEST click here: https://zoom.us/j/99776265285
Learn more about the event: here https://www.efmc-ismc-virtual.org/
Do not miss the talk of EU-OPENSCREEN Director, Wolfgang Fecke, on the EU-OPENSCREEN compound library at the Drug Discovery virtual meeting on July 20, 2020. For more information and registration please see here.
May 25, 2020
EU-OPENSCREEN and the Latvian Institute of Organic Synthesis will organise the 1st EU-OPENSCREEN Baltic Symposium on Chemical Biology. Participants will learn about the unique opportunities offered through our Europe-wide chemical biology research consortium. Bahne Stechmann will present the research performed at EU-OPENSCREEN and Professor Päivi Tammela (University of Helsinki, EU-OPENSCREEN) will inform the participants about the Academic Compound Library of EU-OPENSCREEN and the opportunities for chemists to exchange their compounds with assay providers.
May 12-14, 2020 - Freiburg, Germany
Alessandra Silvestri will represent EU-OPENSCREEN at Dechema in Freiburg, Germany. For more information see here.
Apr 23-24, 2020 - Braunschweig, Germany
The 3rd International Helmholtz Drug Discovery Conference (HDDC 2020) on April 23-24 in Braunschweig is co-organised by our partner Mark Brönstrup at the HZI and will provide a stimulating platform to discuss the state of the art in drug discovery with academic experts and scientists from biotech and pharmaceutical industries. On April 22nd, EU-OPENSCREEN and our partner IME Fraunhofer will co-organise a compound repurposing workshop. Please come along and discuss with us your ideas and workflows for assay design and data analysis. For more information see here.
Mar 28-29, 2020 - Zagreb, Croatia
Alessandra Silvestri will represent EU-OPENSCREEN at the MCAA General Assembly in Zagreb, Croatia. For more information see here.
Mar 23-24, 2020 - Cape Town, South Africa
Bahne Stechmann will co-organise the 1st RI-VIS Africa-Europe Symposium on Research Infrastructures, which will be held on March 23rd- 24th, 2020, in Cape Town, South Africa. This two day symposium will bring together staff from European infrastructures and South African and other African research infrastructures and institutions to initiate new - and strengthen existing - Africa-Europe collaborations. For more information see here.
Mar 18-19, 2020 - Zagreb, Croatia
The ESFRI Conference "European Research Infrastructures for a smarter future" in Zagreb will explore the potential of European Research Infrastructures. Wolfgang Fecke will attend the meeting on behalf of EU-OPENSCREEN. For more information see here.
Mar 3-4, 2020 - Brussels, Belgium
EOSC-Life is the new cluster project of the European life science RIs within the European Open Science Cloud (EOSC), aiming at creating an open collaborative space for digital biology in Europe. Wolfgang Fecke will represent EU-OPENSCREEN on the Executive Board during EOSC Life AGM.
Mar 2, 2020 - Brussels, Belgium
At the CORBEL Final Meeting, the consortium will present their solutions for harmonising user access to the European Life Science research infrastructures (LS RIs). EU-OPENSCREEN is represented on the Corbel Executive Board by Wolfgang Fecke.
Feb 25, Amsterdam, Netherlands
Katja Herzog and Tanja Miletic will represent EU-OPENSCREEN at the ARIA software workshop in Amsterdam. EU-OPENSCREEN has successfully implemented the ARIA software for its project management and collaborates with INSTRUCT ERIC on the further development of the ARIA software. Talk to us, if you would like to profit from our experience. More information and registration can be found here.
Feb 16-18, Munich, Germany
Maren Kappe and Bahne Stechmann will represent EU-OPENSCREEN at the RI-VIS Communication Workshop and AGM in Munich.
Feb 5-6, Brussels, Belgium
Wolfgang Fecke will represent EU-OPENSCREEN at the ERIC Forum Meeting 2020 in Brussels.
Jan 25-29, San Diego, USA
Wolfgang Fecke will present a poster on how EU-OPENSCREEN is "Accelerating chemical tool discovery by a novel collaborative approach". For more information see here.
January 21, Berlin, Germany
Bahne Stechmann will give a presentation on the "Implementation & operation of an ESFRI project" on the example of EU-OPENSCREEN.
Dec 7-11, Washington DC, USA
Do not miss the talk of our Scientific Strategy Officer, Bahne Stechmann, on "How to boost your research project with the support of inernational research infrastructures" at ASCB/EMBO on Tuesday Dec 10, 2019 at 10.00 in theater 4, Exhibit Hall. More information can be found here.
November 27, 2019, Cambridge, UK
Wolfgang Fecke will give a presentation on "Access to EU-OPENSCREEN, the new Research Infrastructure for Chemical Biology" at 4pm, Pfizer Lecture Theatre, Chemistry Department, Lensfield Road, Cambridge. More information on the meeting can be found here.
Nov 25, 2019 Rechovot, Israel
The first ISR-OPENSCREEN workshop "Bringing together small molecules and biology" will take place at the Weizmann Institute of Science in Rechovot, Israel on Nov 25, 2019. At this workshop representatives from our partner sites in the Czech Republic, Norway and Finland will be present. Bahne Stechmann from EU-OPENSCREEN will give a presentation on "The European Research Infrastructure in Chemical Biology and early Drug Discovery". The programme can be found here.
Nov 6-8, 2019 La Palma, Canary Islands
Wolfgang Fecke will represent EU-OPENSCREEN at this meeting to explore key issues that emerged through the roadmap process.
Nov 5-6, 2019 Liverpool, UK
Do not miss Tanja Miletic´s poster presentation on EU-OPENSCREEN at the ELRIG "Looking back to future conference" in Liverpool, UK. For more information visit the conference website.
October 28-30, 2019 Paris, France
Wolfgang Fecke will give a keynote at this conference. For more information visit the conference website.
Oct 1-2nd, 2019, Heidelberg, Germany
Tanja Miletic (Project Manager) and Martin Neuenschwander (Compound Logistics Manager) will represent EU-OPENSCREEN at the meeting.
CORBEL is an initiative of thirteen biological and medical research infrastructures (BMS RIs), which together will create a platform for harmonised user access to biological and medical technologies, biological samples and data services required by cutting-edge biomedical research. Scientists who benefit from transnational open access to dedicated technology platforms through CORBEL will present their project's progress. Their presentations will be complemented by the technology providers from partner sites from research infrastructures giving their view on the project. Not only this meeting will help to advance the individual projects through face-to-face discussions and networking between different technology platforms and external users. The goal of this meeting is also to unveil and subsequently address bottlenecks in the implementation and transition of projects from one research infrastructure to the next.
Kathy Skopelitou will represent EU-OPENSCREEN at the symposium which is organised by our Greek EU-OPENSCREEN partners at the Aristotle University of Thessaloniki. Researchers from academia and industry are invited to participate and discuss about the current status of Chemical Libraries in Europe and future challenges regarding the organization, function and contribution of Chemical Libraries in Research and Economic Development.
Sep 26, 2019, Maceió, Brasil
Bahne Stechmann will give a presentation on "EU-OPENSCREEN - An International Research Infrastructure initiative to facilitate Chemical Biology and early Drug Discovery" at the 51st Congress of SBFTE (Brazilian Society of Pharmacology and Experimental Therapeutics, in Maceió on September 26th.
The presentation is part of the Symposium on 'Main Challenges for Innovation in Pharmacology'. The theme of the congress is 'Challenging frontiers in Pharmacology' and 600-700 scientists, including graduate students and postdocs, will attend. The presentation aims to initiate new collaborations with Brazilian researchers and is part of EU-OPENSCREEN's initiative to build new partnerships with Latin American countries.
The presentation will explain how assay providers from Brazil can use the EU-OPENSCREEN compound collection to develop, in collaboration with EU-OPENSCREEN partner sites, novel chemical probes, and how Brazilian chemists and pharmacologists can collaborate with EU-OPENSCREEN to identify biological activities of their compounds.
For more info see here.
Sep 25-28, 2019, Poznan, Poland
Wolfgang Fecke (EU-OPENSCREEN Director General) will represent EU-OPENSCREEN at the conference. Jacek Kolanowski from our local Partnersite, the Institute of Bioorganic Chemistry (IBCH) at the Polish Academy of Sciences, will give an up-date on the activities within the EU-Horizon 2020 grant, EU-OPENSCREEN DRIVE, which enhances the sustainability and operational excellence of EU-OPENCREEN and its services. Attendees will also have the opportunity to visit the EU-OPENSCREEN Partner Site Institute of Bioorganic Chemistry (IBCH).
ICBB2019 is co-organized byour EU-OPENSCREEN screening partner site, the Institute of Bioorganic Chemistry, Polish Academy of Sciences, Asia-Pacific Association of Science, Engineering and Technology, Adam Mickiewicz University, and Chinese Journal of Biologicals, in collaboration with multiple academic affiliations.
More info here.
Sep 25, Brussels, Belgium
Wolfgang Fecke will represent EU-OPENSCREEN at this meeting of Top Roadmap Stakeholders in Brussels.
Sep 9-12th, 2019, Basel, Switzerland
BASEL LIFE is Europe’s leading congress in the Life Sciences, showcasing cutting-edge science and technology, and more than 2,000 participants are expected. If you attend the BASEL LIFE Miptec 2019 in Basel on September 9-12, stop by at our booth 'European Research Infrastructures', which is organized by EU-OPENSCREEN (represented by our European Relations and Grant Officer Dr. Katja Herzog) and Instruct-ERIC.
EU-OPENSCREEN offers open-access to a network of partner sites throughout Europe who work in Chemical Biology and early Drug Discovery. As a research infrastructure, EU-OPENSCREEN collaborates with international scientists from academia and industry to facilitate research in early Drug Discovery. Instruct-ERIC offers open-access to a wide range of high end structural biology technologies across Europe, such as cryo-Electron microscopy, NMR, x-ray diffraction and mass spectrometry, as well as training and internships. Discuss with us how you can use these valuable resources to address your research questions.
Program here.
More info here.
Sep 8-11, 2019, Istanbul, Turkey
Meet and discuss with Bahne Stechmann at the Asian Federation for Medicinal Chemistry (AFMC) 12th International Symposium 'New Avenues for Design and Development of Translational Medicine' in Istanbul on September 8-11th .
EU-OPENSCREEN offers international medicinal and organic chemists the opportunity to profile their compounds and integrate them into the EU-OPENSCREEN academic compound collection, which will be screened by EU-OPENSREEN's partner sites and thereby uncovers the biological activities of these compounds. Thanks to EU-OPENSCREEN's pan-European network of partner sites, the compounds will be tested in a large number of screens, and thereby exposed to a wide range of biological targets.
Bahne will present the poster 'EU-OPENSCREEN - Innovative collaboration models in early drug discovery'.
For more information see here.
July 8-11, 2019 University of the Basque Country, Vitoria-Gasteiz (Spain)
On July 8 at 09:35-09:50 in room OC-11, Jordi Quintana will give a talk on “EU-OPENSCREEN drive: building the European academic chemical library”. For more information see here.
July 6-11th 2019, Krakow, Poland
Bahne Stechmann (EU-OPENSCREEN Scientific Strategy Manager) will be present at the meeting.
The FEBS Congress has become a unique collaboration between FEBS and its Constituent Societies (the biochemistry and molecular biology societies across Europe and neighbouring regions that belong to FEBS), with the organization of the event awarded to a different host Society each year. While the event retains the core elements that make it 'The FEBS Congress' (under the guidance of FEBS), this approach enables each host Society to bring a local flavour and fresh ideas to the meeting, and also gives opportunities for participants to explore new locations. Although always taking place in the FEBS area, the FEBS Congress attracts scientists from across the globe, and you do not need to be a member of a FEBS Constituent Society to take part.
Program here.
More infos here.
June 19th, 2019, Rehovot, Israel
Wolfgang Fecke (EU-OPENSCREEN Director General) will represent EU-OPENSCREEN with a booth at the Weizmann Institute of Science.
More infos here.
26-28 June, 2019, Barcelona, Spain
The EU-OPENSCREEN partner site Fundacion MEDINA will be presenting the recent innovations at the SLAS Europe Meeting in Barcelona from June 26-28. The Head of Screening and Target Validation, Francisca Vicente, will be speaking about implementations of HTS in Natural Products in the Labcyte Tutorial: “Beyond Small Molecule Screening with the Echo® Liquid Handlers and Access™ Workstations” on Thurs June 27th at 8:30 a.m. in Room 118.
More and more researchers are applying innovative technologies beyond the world of small molecules in the search for novel therapeutic targets and therapies. Presentations from LifeArc, Fundación MEDINA, and University Hospital of Zurich will discuss about implementations using the Echo® Liquid Handlers and the Access™ Workstation for high-throughput screening of fragments, natural products, and antibodies. In addition, the Principal Scientist, Carmen Ramos, will be presenting the poster entitled “P069-Spheroids 3D culture, a powerful tool in Drug Discovery screening in cancer research” on Thurs June 27th at 1:15 pm.
Cancer is a leading cause of death worldwide in spite of numerous efforts made in anticancer drug discovery. One of the reasons is the inefficient drug discovery models using a classic 2D cell culture, since it cannot recreate in vivo conditions.
For this reason, 3D tumor cell culturing has emerged to more closely simulate these conditions. In order to evaluate the cytotoxicity of potential antitumor drugs, MEDINA has included two approaches based on spheroids culture: the high-throughput method for measuring viability assays, and an image-based assay with three-dye staining method (calcein AM, propidium iodide and Hoechst) which provides insight into the mechanism of cytotoxicity. By applying this method, it is possible to distinguish active compounds that kill tumor cells within the spheroid, other compounds that disintegrate the spheroid/tumor, and others that reduce the spheroid size. These findings increase the value of the active compound discovered.
Sona Gurska from the High throughput screening and High content analysis core at our EU-OPENSCREEN partner site in Olomouc, Poland, (Univerzita Palackeho V Olomouci) and Jana Kotulova, both under the leadership of Petr Džubák, are presenting a poster (No 91) with the title "A high-throughput, whole cell-based assay for cytotoxicity profiling of new chemical compounds".
For more information on SLAS Europe 2019 see here.
June 11-12th, 2019, Berlin, Germany
Wolfgang Fecke (EU-OPENSCREEN Director General) and Tanja Miletic (Project Manager) will be present at the Drug Discovery Summit.
The R&D Europe Series unites over 400 drug discovery attendees from global pharmaceutical organisations, top biotech companies and internationally renowned academic institutions specialising in various therapeutic areas. This renowned series of events provide a valuable opportunity for leaders to transform and lead the future of drug discovery and development.
An invaluable resource for those looking to improve efficiency, increase pipelines and keep up to date with the latest advances. Looking at small molecules and biologics, this congress will feature key insights into protein degradation, AI/ML in drug discovery and provide updates in screening and modelling including CRISPR and organ-on-a-chip techniques. Key therapeutic areas include: immunotherapy and oncology.
Bringing you the latest in discovery enabling technologies, computational based drug design and discovery chemistry, this congress bring together leading figures in the field to discuss the evolving techniques being utilised in the sector. Key focus areas include; DNA encoded libraries, protein-protein interactions, AI/ML in drug design and medicinal chemistry for oncology.
Companies at the forefront of this field, including Amgen, Genentech, F star, Merus and Numab will present their insights on bispecific drug discoveries using the novel applications and engineering technologies as well as bispecific therapeutic development beyond immune-oncology. Key focus areas include developability, immunogenicity, safety and CMC considerations to bring bispecifics into the clinic successfully.
The Congress will bring together a host of key experts from this new and exciting field, examining the latest advances in neuroscience research, both in target identification & validation-led approaches. Case Studies will include a focus on the tools & technologies enabling novel treatment developments, critical biomarker & translational work in preclinical development, alongside an overview of the current and ongoing successful collaborative models of research between the pharmaceutical industry and clinical institutions.
Drug discovery agenda here.
Other agendas (Neuroscience, Bispecific, Discovery Chemistry) can be requested through this website.
More infos here.
May 22nd-24th 2019, Madrid (Alcalá de Henares), Spain
Katja Herzog will attend the conference with a booth and represent the CORBEL project there as well.
The 4th Instruct Biennial Structural Biology Conference will take place in Alcalá de Henares, Spain, from May 22 till May 24, 2019. The historical Alcalá de Henares was the original location of the Universidad Complutense, founded in 1293 and one of the oldest universities in the world, as well as being the birthplace of Miguel de Cervantes. The social programme of the meeting will include a visit to the city, a gala dinner and extensive opportunities to network with the Instruct Structural Biology community.
More infos here.
May 22-23rd, 2019, Gothenburg, Sweden
The third ELRIG meeting on Advances in Cell Based Profiling in Drug Discovery will be held at the AstraZeneca R&D premises in Gothenburg. This interactive 2-day event will host leading scientists from academia and industry to discuss current and future formats for cell based assays. This time the bi-annual meeting will be accompanied by a satellite meeting on Chemical Biology on May 24th, organized by our EU-OPENSCREEN collaborators from the Chemical Biology Consorium Sweden (CBCS) and other academic infrastructures in the Nordic countries. The aim is to create an open and inspiring environment for networking between biologists and chemists, working towards a common view on expectations from our cell assays and their use for target identification, target validation and compound profiling purposes.
Plenary Keynote Speakers: Herbert Waldmann (Max Planck Institute of Molecular Physiology, Dortmund, Olli Kallioniemi (SciLifeLab, KI, Stockholm), Ulli Elling (Institute of Molecular Biotechnology, IMBA, Vienna), Craig Crews (Yale University).
Cell based assays are utilized at all stages of drug discovery to explore disease mechanisms and to identify novel molecular therapeutics. Significant advancements are being made towards cell reagents and formats that provide a more accurate biological context, aiming at improving translation to human physiology/pathophysiology. Their implementation is much needed for improving success rates in drug discovery, but there are significant challenges associated with reliable and affordable reagent supply and validation of improved translational power to justify costs. This meeting serves to explore recent advancements and to discuss their practical implementation in drug and chemical probe discovery and validation.
More infos here.
May 7th, 2019, Berlin, Germany
Philip Brennecke (Scientific Project Officer) will represent EU-OPENSCREEN at the meeting.
BIONNALE is the biggest networking event for life sciences and healthcare industries in the German capital region. Representatives from academia and industry attend the annual life sciences event in Berlin to identify, engage and start strategic relationships. The networking character is one strength of BIONNALE with more than 900 attendees from over 20 countries in the last year.
Agenda here.
More infos here. #BIONNALE
April 10th, 2019, Berlin, Germany
Jens von Kries and research team, Marc Nazare and research team (EU-OPENSCREEN partner site FMP-FVB), Wolfgang Fecke, Ronald Frank and Katja Herzog (EU-OPENSCREEN) were present at the meeting.
This year, the symposium will highlight the latest developments in the field of small molecules. Two international key notes, Hana Algül from the Klinikum rechts der Isar der Technischen Universität München and Stefano Piccolo from the University of Padova, Italy, will present their work. Further experts from industry and academia will present their current projects and challenges. A poster session in the afternoon break and a get-together in the evening will provide plenty of time for networking.
Program and more infos here.
April 6-9th 2019, Orlando, FL, US
Bahne Stechmann (EU-OPENSCREEN) was present at the meeting and presented a poster on acccess opportunities for scientific user projects within EU-OPENSCREEN.
Break ground on new discoveries. The 2019 ASBMB Annual Meeting is where leading experts and scientists at all points on their career trajectories convene to share new research. It’s your chance to go beyond your everyday routine and discuss your work with influencers in your specialty. Attend inspiring lectures and hands-on workshops, connect with peers in the biochemistry and molecular biology community, and gain inspiration to take back to the lab. Join us at the pinnacle of scientific exchange April 6–9 in Orlando.
Program here.
More infos here.
April, 3rd-5th in Madrid, Spain
EU-OPENSCREEN ERIC is co-organiser and the whole team will be there to meet you!
Chemical biologists from all parts of Europe and overseas come together to present and discuss the latest achievements in cutting edge chemical sciences. This present joint meeting gathers researchers from organic & biological chemistry, proteins biotechnology, computational biology, protocells, machine learning, bacterial resistance, drug discovery, synthetic biology, biomedical materials and chemical glycobiology. We encourage young researchers to present their work at the meeting (oral & flash presentations will be selected from abstracts), discuss with the speakers and embrace the exciting developments currently happening in chemical biology.
Program here.
More infos on the conference here.
March 14th-15th 2019, Berlin, Germany
Katja Herzog (EU-OPENSCREEN) will present a poster on the access models to EU-OPENSCREEN services.
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
More infos here.
March 11-12, Berlin, Germany
Edgar Specker (FMP Berlin) and Bahne Stechmann (EU-OPENSCREEN) will present the concept of EU-OPENSCREEN and outline the compound management operation at the FMP and EU-OPENSCREEN at the 'Working in Partnership' session of the SLAS 2019 European Sample Management Symposium.
More information here.
Tuesday, February 5th, 4.30-5pm in Washington, USA
Dr. Wolfgang Fecke, director of EU-OPENSCREEN ERIC, will give the talk "A novel European Compound Screening Library for EU-OPENSCREEN" in the "Small molecule libraries" session/podium discussion at the SLAS 2019 in Washington, USA. Looking forward to meeting you there!
Location at conference: 146C
More infos:
Meet EU-OPENSCREEN (Dr. Katja Herzog) at the Berlin Science Week.
ATTENTION: Event language will be German.
FUTURE 4.0 THE FUTURE WILL BE GOOD. BECAUSE WE MAKE IT!
Ladies and Gentlemen, Let us shape the future together. We therefore invite you to the Berlin Science Week - to our event Future 4.0: Work, Products, Locations on 8 November 2018, 15:00 o'clock - 21:00 o'clock to the Technical University of Berlin (Lichthof in the main building, Straße des 17. Juni 135, 10623 Berlin)
Get to know Berlin's places of the future and meet interesting companies that will shape the products of the future with you. Get in touch with scientific institutions that will also put your ideas of tomorrow into practice. Find out about the places where all the knowledge and skills come together.
We would like to draw your special attention to two highlights:
Keynote lecture: "What does theory say: How will we work in the future? In which areas will our working environments change?" Prof. Dr. Hoppe, Humboldt University Berlin
Panel discussion: "What does a modern future location have and need? Participants: Jutta Heim-Wenzler (Tempelhof Projetion GmbH), Corinna Huge (Senate Administration for Economics, Energy and Business), Dr. Christina Quensel (Campus Berlin-Buch GmbH), Roland Sillmann (WISTA Management GmbH), Thomas Henn (VIRTENIO GmbH), Moderation: Ingo Hoppe
We are looking forward to seeing you!
Ljubljana, Slovenia, September 2-6, 2018
Philip Brennecke will present EU-OPENSCREEN in Ljubljana. For more information see here: www.ldorganisation.com/v2/produits.php
Vienna, Austria, September 12-14, 2018
Wolfgang Fecke will represent EU-OPENSCREEN in Vienna. For more information see here: www.icri2018.at
San Diego, USA, December 8-12, 2018
Bahne Stechmann will present EU-OPENSCREEN in San Diego. For more information see here: ascb-embo2018.ascb.org/symposia/
Prague, Czech Republic, July 7-12, 2018
Bahne Stechmann (EU-OPENSCREEN) and Naomi Gray (INSTRUCT) are jointly organising the session "European Research Infrastructures: Find your collaboration partner in structural biology and chemical biology" at the 43rd FEBS 2018 Congress in Prague. Find out how you can benefit from services provided by Instruct-ERIC and EU-OPENSCREEN ERIC, and hear two interesting examples of recent research from leading scientists using these technologies: Dr Jan Dohnálek, Group leader at the Biotechnology and Biomedicine Center of the Academy of Sciences and Charles University in Vestec (BIOCEV) will present his NMR based studies at the Instruct-ERIC centre on Zn-dependent nucleases from plants, fungi and bacterial pathogens. Dr Petr Bartunek, Director of CZ-OPENSCREEN, the National Infrastructure for Chemical Biology, and Group leader at the Institute of Molecular Genetics at Academy of Sciences in Prague will present the Czech infrastructure for Chemical Biology and explain how external biologists can collaboratively develop their own probes by using the state-of-the-art facilities within CZ-OPENSCREEN.
Recent in-silico approaches will be discussed as well as their applications in academic drug discovery efforts including drug repurposing and high-throughput combinatorial approaches to guide the biologist to select appropriate high-quality probes for their experiments.
For more information: 2018.febscongress.org
Berlin, Germany, July 7-11, 2018
EU-OPENSCREEN is jointly organising with Euro-BioImaging and INSTRUCT the networking session "New Horizons in Neuroscience: Solving membrane protein structures; biological and medical imaging; and high throughput drug screening". This session is a unique opportunity to network with other neuroscientists and find out about opportunities to benefit from free training and research visits to high end laboratories across Europe offering access to the latest technologies including cryo-Electron Microscopy, Xray spectroscopy, NMR, Nanobody discovery, selective plane illumination microscopy (SPIM), super resolution microscopy, multi-modal molecular imaging and high throughput drug screen technologies.
Professor Radu Aricescu from the University of Cambridge will present his latest research in the area of GABA receptor structure and function allowing fresh insights into inhibitory neurotransmission. He will share his experience in working with European research infrastructures and how open access to high-end technologies can enable cross-disciplinary, pioneering research projects.
For more information, please see here.
San Diego, USA, April 21-25, 2018
'CORBEL', a Horizon 2020-funded initiative of eleven biomedical research infrastructures, launched a call for collaborative research projects, which generated a lot of interest among European scientists and over 20 projects have been accepted. As CORBEL will launch a second call for projects in early 2018, Bahne Stechmann will highlight the success of the first CORBEL call and the research opportunities that research infrastructures represent to molecular biologists and biochemists at the annual meeting of the ASBMB.
Loutraki, Greece, March 21-24, 2018
EU-OPENSCREEN is a member of the Horizon 2020-funded project 'CORBEL' which enables complex research projects that require the expertise and technologies of several research infrastructures. Bahne Stechmann will present CORBEL at the European Cystic Fibrosis Society (ECFS) Basic Science Conference to illustrate these new research opportunities to the cystic fibrosis community.
FESTO, Esslingen (Stuttgart), February 28, 2018
Philip Gribbon will represent EU-OPENSCREEN at the ELRIG Meeting on "Robotics & Automation" in Esslingen, Germany.
Frankfurt, Germany
January 30-31, 2018
Katja Herzog and Philip Gribbon will represent EU-OPENSCREEN at the DECHEMA Meeting "Advances in Chemical Biology" in Frankfurt, Germany.
Philadelphia, USA
December, 2-6
EU-OPENSCREEN, together with Euro-BioImaging and INSTRUCT, organises a session on "New Opportunities for Researchers – Open Access to Transnational Research Infrastructures in Imaging, Structural Biology, and Compound Screening" at the upcoming EMBO-ASCB Conference. The session will take place on Sunday, 11:00-12:00 am. Bahne Stechmann presents EU-OPENSCREEN.
Shanghai, China
October, 17-20
Bahne Stechmann will give a presentation on EU-OPENSCREEN during a Special Session on the "Global chemical biology landscape" at the upcoming International Chemical Biology Sympoisum (ICBS) on Thursday, October 19th.
Zürich, Switzerland
October, 12-13
Katja Herzog will represent EU-OPENSCREEN at the SIBS 2017 Congess in Zurich.
Prague, Czech Republic
September 24-26
Katja Herzog will represent EU-OPENSCREEN at the Translational Medicine 2017 EATRIS Conference in Prague.
Jerusalem, Israel
September, 10-14
Bahne Stechmann will give an early bird session on "New European research infrastructures in imaging, structural biology and compound screening: how to take advantage as a researcher? ".
Vienna, Austria
August, 27-31
Bahne Stechmann will represent EU-OPENSCREEN.
Helsinki, Finland
May 9-10
Katja Herzog and Bahne Stechmann will represent EU-OPENSCREEN.
Brno, Czech Republic
May 24
Bahne Stechmann will represent EU-OPENSCREEN.
Munich, Germany
May 29-30
Maren Kappe will represent EU-OPENSCREEN.
Copenhagen, Denmark
June 6-7, 2017
The Conference Chair will be our Danish EU-OPENSCREEN partner Mads Clausen. Numerous other EU-OPENSCREEN partners such as Per-Anders Enquist (Umea University), Anna-Lena Gustafsson (CBCS), Jeanette Hammer Andersen (Tromso University), Krister Wennerberg (FIMM) and our coordinator Philip Gribbon will participate in the scientific committee and the meeting.
Brussels, Belgium
June 20, 2017
Katja Herzog will represent EU-OPENSCREEN at this event.
Budapest, Hungary
July 2-4, 2017
The ECBS 2017 is organised by our Hungarian EU-OPENSCREEN partners Attila Reményi and György Dormán and many other EU-OPENSCREEN partners will be joining the conference. Philip Gribbon from the EU-OPENSCREEN head office will participate here.
Berlin, Germany
March 14-15, 2017
Philip Gribbon and Bahne Stechmann represented EU-OPENSCREEN here.
Cambridge, UK
March 6-7, 2017
Edgar Specker, Head of Compound Management, Medicinal Chemistry Group, FMP Leibniz Institute for Molecular Pharmacology presented on "Structure Based Drug Design of Tryptophan Hydroxylase (TPH) Inhibitors Exploiting the Binding Pocket of the Co-Substrate Pterin".
Tel Aviv, Israel
February 13-14, 2017
Haim Barr represented EU-OPENSCREEN here.
Washington, DC
February 4-8, 2017
Philip Gribbon represented EU-OPENSCREEN here.
Berlin, Germany, June 27-29, 2016
Project Coordinator Philip Gribbon presented EU-OPENSCREEN at the MACUMBA conference focusing on the biotechnical application of marine microbes in Berlin Adlershof.
Madison, USA, October 24-26, 2016
Project Coordinator Philip Gribbon presented EU-OPENSCREEN at ICBS 2016 in Madison, Wisconsin, US
Berlin, Germany, April 12-13, 2016
Project coordinator Philip Gribbon presented EU-OPENSCREEN at the SLAS Conference on Compound Management in Industry and Academia in Berlin, Germany.